Varian ranked first in oncology IT vendors
16 July 2008
Varian Medical Systems (NYSE:VAR) was ranked the leading supplier in
its class in an independent study released by KLAS, a research firm that
specialises in monitoring and reporting on the performance of healthcare
vendors.
Varian's ARIA software, an information system for managing medical
and radiation oncology practices, received top scores in study
categories including: ease of use, quality of releases and updates, and
compatibility with third party products.
According to the June 2008 Oncology report, Varian Medical Systems is
"considered by many providers to have the most developed and
comprehensive oncology solution". The report further states that "many
Varian customers feel that the ARIA suite is the most robust solution
for medical and radiation oncology available on the market today."
KLAS interviewed eleven potential vendors, but only three had
sufficient number of active installations to qualify, the other two
being IMPAC, and IntrinsiQ.
Varian was the only vendor to score above the group average in all
four of the report's major categories: product/technology indicators,
service indicators, success indicators, and business indicators. Varian
scored above competitors in 23 of the forty indicators that the study
measured.
The KLAS study predicts that Varian will continue to be seen as one
of the most complete medical and radiation oncology solutions for some
time to come.
"We're gratified to receive top marks in an objective survey of our
customers," said Dow Wilson, president of the company's Oncology Systems
business. "It validates the work we're doing to offer treatment centers
a versatile set of best-in-class clinical tools for fighting cancer."